TY - JOUR
T1 - Exercise training for cardiovascular prevention in patients with cancer
T2 - A scientific statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology
AU - Piepoli, Massimo
AU - Cohen-Solal, Alain
AU - Ameri, Pietro
AU - Totzeck, Matthias
AU - Anker, Markus S
AU - Fervers, Beatrice
AU - Lehmann, Lorenz H
AU - de Keulenaer, Gilles
AU - McLaughlin, Marie
AU - Wilhelm, Matthias
AU - D'Ascenzi, Flavio
AU - Agostoni, Piergiuseppe
AU - Halle, Martin
AU - Scott, Jessica M
AU - Jones, Lee W
AU - Van Craenenbroeck, Emeline
AU - Von Haehling, Stephan
AU - Keramida, Kalliopi
AU - Adamopoulos, Stamatis
AU - Bayes-Genis, Antoni
AU - Sule, Elena Marques
AU - Mouine, Najat
AU - Niederseer, David
AU - Orso, Francesco
AU - Halasz, Geza
AU - Paolillo, Stefania
AU - Vergaro, Giuseppe
AU - Mbakwem, Amam Chinyere
AU - Iakobishvili, Zaza
AU - Koop, Yvonne
AU - Sverdlov, Aaron
AU - Skouri, Hadi
AU - Asteggiano, Riccardo
AU - Suter, Thomas
AU - Lopez-Fernandez, Teresa
AU - Lyon, Alexander
AU - Farmakis, Dimitrios
AU - Moura, Brenda
AU - Chioncel, Ovidiu
AU - Seferovic, Petar
AU - Coats, Andrew J S
AU - Metra, Marco
AU - Rosano, Giuseppe
AU - Tocchetti, Carlo G
AU - Volterrani, Maurizio
N1 - © The European Society of Cardiology 2026. All rights reserved. For permissions, please email: [email protected].
PY - 2026/9/14
Y1 - 2026/9/14
N2 - Patients with cancer usually report limitations of their functional capacity, which may range from subclinical impairment of cardiopulmonary exercise reserve to poor quality of life with physical, cognitive, or psychosocial consequences. Exercise training is a potent multi-targeted approach to control pre-existing and new risk factors. Preliminary evidence shows that it is associated with a lower risk of cancer therapy-related cardiotoxicity and increased self-reported well-being in patients with cancer. Current evidence demonstrates that supervised exercise therapy, including high-intensity interval training, is safe and well-tolerated and reduces risk in subjects with cancer in the pre-, active-, and post-treatment settings. The present consensus document will discuss the role of exercise training in cardio-oncology, focusing on patients with cardiovascular diseases induced by cancer treatment and on those who received cardiotoxic therapies.
AB - Patients with cancer usually report limitations of their functional capacity, which may range from subclinical impairment of cardiopulmonary exercise reserve to poor quality of life with physical, cognitive, or psychosocial consequences. Exercise training is a potent multi-targeted approach to control pre-existing and new risk factors. Preliminary evidence shows that it is associated with a lower risk of cancer therapy-related cardiotoxicity and increased self-reported well-being in patients with cancer. Current evidence demonstrates that supervised exercise therapy, including high-intensity interval training, is safe and well-tolerated and reduces risk in subjects with cancer in the pre-, active-, and post-treatment settings. The present consensus document will discuss the role of exercise training in cardio-oncology, focusing on patients with cardiovascular diseases induced by cancer treatment and on those who received cardiotoxic therapies.
KW - Cardio-oncology
KW - Exercise training
UR - https://www.scopus.com/pages/publications/105050491955
U2 - 10.1093/eurheartj/ehag089
DO - 10.1093/eurheartj/ehag089
M3 - Review article
C2 - 42455638
SN - 0195-668X
VL - 47
SP - 4869
EP - 4883
JO - European heart journal
JF - European heart journal
IS - 35
ER -